tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

InnoCare Pharma Announces Grant of Restricted Shares Under 2024 Incentive Scheme
Company AnnouncementsInnoCare Pharma Announces Grant of Restricted Shares Under 2024 Incentive Scheme
21d ago
9969
InnoCare Pharma Grants 210,000 RSUs to Key Employees Under 2023 Scheme
PremiumCompany Announcements
InnoCare Pharma Grants 210,000 RSUs to Key Employees Under 2023 Scheme
21d ago
9969
InnoCare Pharma Sees Robust Revenue Growth Amidst Reduced Losses
PremiumCompany Announcements
InnoCare Pharma Sees Robust Revenue Growth Amidst Reduced Losses
22d ago
9969
InnoCare Pharma Schedules Board Meeting for Interim Results
PremiumCompany Announcements
InnoCare Pharma Schedules Board Meeting for Interim Results
1M ago
9969
InnoCare Pharma Successfully Passes All Resolutions at AGM
PremiumCompany Announcements
InnoCare Pharma Successfully Passes All Resolutions at AGM
3M ago
9969
InnoCare Pharma Gains NMPA Approval for Minjuvi in China
PremiumCompany AnnouncementsInnoCare Pharma Gains NMPA Approval for Minjuvi in China
4M ago
9969
InnoCare Pharma Ltd.: Strong Financial Performance and Promising Pipeline Drive Buy Rating
Premium
Ratings
InnoCare Pharma Ltd.: Strong Financial Performance and Promising Pipeline Drive Buy Rating
4M ago
InnoCare Pharma Releases Unaudited Q1 2025 Financial Data
Premium
Company Announcements
InnoCare Pharma Releases Unaudited Q1 2025 Financial Data
4M ago
9969
InnoCare Pharma Announces 2025 Annual General Meeting and Key Resolutions
PremiumCompany Announcements
InnoCare Pharma Announces 2025 Annual General Meeting and Key Resolutions
5M ago
9969
InnoCare Pharma to Review Q1 2025 Financial Results
PremiumCompany Announcements
InnoCare Pharma to Review Q1 2025 Financial Results
5M ago
9969
InnoCare Pharma’s Orelabrutinib Gains Approval for First-Line CLL/SLL Treatment in China
PremiumCompany Announcements
InnoCare Pharma’s Orelabrutinib Gains Approval for First-Line CLL/SLL Treatment in China
5M ago
9969
InnoCare Pharma Updates Use of RMB Share Issue Proceeds
PremiumCompany Announcements
InnoCare Pharma Updates Use of RMB Share Issue Proceeds
6M ago
9969
InnoCare Pharma Enhances Governance with New Nomination Committee
PremiumCompany AnnouncementsInnoCare Pharma Enhances Governance with New Nomination Committee
6M ago
9969
InnoCare Pharma Reports Strong Revenue Growth and Improved Profit Margins for 2024
Premium
Company Announcements
InnoCare Pharma Reports Strong Revenue Growth and Improved Profit Margins for 2024
6M ago
9969
InnoCare Pharma Schedules Board Meeting for Annual Results Approval
Premium
Company Announcements
InnoCare Pharma Schedules Board Meeting for Annual Results Approval
6M ago
9969
InnoCare Pharma Presents Promising Phase II Data for Psoriasis Drug
PremiumCompany Announcements
InnoCare Pharma Presents Promising Phase II Data for Psoriasis Drug
6M ago
9969
InnoCare Pharma Reports Promising Phase II Results for MS Treatment
PremiumCompany Announcements
InnoCare Pharma Reports Promising Phase II Results for MS Treatment
7M ago
9969
InnoCare Pharma Gains Approval for Phase III Clinical Trial of CLL/SLL Treatment
PremiumCompany Announcements
InnoCare Pharma Gains Approval for Phase III Clinical Trial of CLL/SLL Treatment
7M ago
9969
InnoCare Pharma Appoints Renowned Scientist as Independent Director
PremiumCompany Announcements
InnoCare Pharma Appoints Renowned Scientist as Independent Director
8M ago
9969
InnoCare Pharma Updates Board of Directors and Roles
PremiumCompany AnnouncementsInnoCare Pharma Updates Board of Directors and Roles
8M ago
9969
InnoCare Pharma Enters Licensing Agreement with Prolium for Innovative Antibody Development
Premium
Company Announcements
InnoCare Pharma Enters Licensing Agreement with Prolium for Innovative Antibody Development
8M ago
9969
InnoCare Pharma Projects Significant Revenue Growth and Reduced Losses for 2024
Premium
Company Announcements
InnoCare Pharma Projects Significant Revenue Growth and Reduced Losses for 2024
8M ago
9969

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >